You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 21, 2024

Details for New Drug Application (NDA): 020267

✉ Email this page to a colleague

« Back to Dashboard

NDA 020267 describes JUNIOR STRENGTH ADVIL, which is a drug marketed by Haleon Us Holdings and is included in two NDAs. It is available from two suppliers. Additional details are available on the JUNIOR STRENGTH ADVIL profile page.

The generic ingredient in JUNIOR STRENGTH ADVIL is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and thirty-four suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 020267
Applicant:Haleon Us Holdings
Formulation / Manufacturing:see details
Pharmacology for NDA: 020267
Mechanism of ActionCyclooxygenase Inhibitors
Suppliers and Packaging for NDA: 020267
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
JUNIOR STRENGTH ADVIL ibuprofen TABLET;ORAL 020267 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0573-0175 0573-0175-11 1 BOTTLE in 1 CARTON (0573-0175-11) / 24 TABLET, COATED in 1 BOTTLE

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength100MG
Approval Date:Dec 13, 1996TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.